Wabwire-Mangen F - Search Results

1

Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif.

Eller MA, Koehler RN, Kijak GH, Eller LA, Guwatudde D, Marovich MA, Michael NL, de Souza MS, Wabwire-Mangen F, Robb ML, Currier JR, Sandberg JK. Eller MA, et al. J Virol. 2011 May;85(10):4802-11. doi: 10.1128/JVI.00111-11. Epub 2011 Mar 16. J Virol. 2011. PMID: 21411516 Free PMC article.

2

Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays.

Singer DE, Kiwanuka N, Serwadda D, Nalugoda F, Hird L, Bulken-Hoover J, Kigozi G, Malia JA, Calero EK, Sateren W, Robb ML, Wabwire-Mangen F, Wawer M, Gray RH, Sewankambo N, Birx DL, Michael NL. Singer DE, et al. J Clin Microbiol. 2005 Oct;43(10):5312-5. doi: 10.1128/JCM.43.10.5312-5315.2005. J Clin Microbiol. 2005. PMID: 16208006 Free PMC article.

3

Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda.

Arroyo MA, Sateren WB, Serwadda D, Gray RH, Wawer MJ, Sewankambo NK, Kiwanuka N, Kigozi G, Wabwire-Mangen F, Eller M, Eller LA, Birx DL, Robb ML, McCutchan FE. Arroyo MA, et al. J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):440-5. doi: 10.1097/01.qai.0000243053.80945.f0. J Acquir Immune Defic Syndr. 2006. PMID: 16980909

4

Large-scale human immunodeficiency virus rapid test evaluation in a low-prevalence ugandan blood bank population.

Eller LA, Eller MA, Ouma BJ, Kataaha P, Bagaya BS, Olemukan RL, Erima S, Kawala L, de Souza MS, Kibuuka H, Wabwire-Mangen F, Peel SA, O'Connell RJ, Robb ML, Michael NL. Eller LA, et al. J Clin Microbiol. 2007 Oct;45(10):3281-5. doi: 10.1128/JCM.00894-07. Epub 2007 Aug 15. J Clin Microbiol. 2007. PMID: 17699650 Free PMC article.

5

Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans.

Eller MA, Eller LA, Opollo MS, Ouma BJ, Oballah PO, Galley L, Karnasuta C, Kim SR, Robb ML, Michael NL, Kibuuka H, Wabwire-Mangen F, Graham BS, Birx DL, de Souza MS, Cox JH. Eller MA, et al. Vaccine. 2007 Nov 7;25(45):7737-42. doi: 10.1016/j.vaccine.2007.08.056. Epub 2007 Sep 17. Vaccine. 2007. PMID: 17920731 Clinical Trial.

6

Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection.

Kiwanuka N, Laeyendecker O, Robb M, Kigozi G, Arroyo M, McCutchan F, Eller LA, Eller M, Makumbi F, Birx D, Wabwire-Mangen F, Serwadda D, Sewankambo NK, Quinn TC, Wawer M, Gray R. Kiwanuka N, et al. J Infect Dis. 2008 Mar 1;197(5):707-13. doi: 10.1086/527416. J Infect Dis. 2008. PMID: 18266607

7

Reference intervals in healthy adult Ugandan blood donors and their impact on conducting international vaccine trials.

Eller LA, Eller MA, Ouma B, Kataaha P, Kyabaggu D, Tumusiime R, Wandege J, Sanya R, Sateren WB, Wabwire-Mangen F, Kibuuka H, Robb ML, Michael NL, de Souza MS. Eller LA, et al. PLoS One. 2008;3(12):e3919. doi: 10.1371/journal.pone.0003919. Epub 2008 Dec 11. PLoS One. 2008. PMID: 19079547 Free PMC article.

8

Relatively low HIV infection rates in rural Uganda, but with high potential for a rise: a cohort study in Kayunga District, Uganda.

Guwatudde D, Wabwire-Mangen F, Eller LA, Eller M, McCutchan F, Kibuuka H, Millard M, Sewankambo N, Serwadda D, Michael N, Robb M; Kayunga Cohort Research Team. Guwatudde D, et al. PLoS One. 2009;4(1):e4145. doi: 10.1371/journal.pone.0004145. Epub 2009 Jan 7. PLoS One. 2009. PMID: 19127290 Free PMC article.

9

HLA class I allele and haplotype diversity in Ugandans supports the presence of a major east African genetic cluster.

Kijak GH, Walsh AM, Koehler RN, Moqueet N, Eller LA, Eller M, Currier JR, Wang Z, Wabwire-Mangen F, Kibuuka HN, Michael NL, Robb ML, McCutchan FE. Kijak GH, et al. Tissue Antigens. 2009 Mar;73(3):262-9. doi: 10.1111/j.1399-0039.2008.01192.x. Tissue Antigens. 2009. PMID: 19254258

10

Contraceptive use in women enrolled into preventive HIV vaccine trials: experience from a phase I/II trial in East Africa.

Kibuuka H, Guwatudde D, Kimutai R, Maganga L, Maboko L, Watyema C, Sawe F, Shaffer D, Matsiko D, Millard M, Michael N, Wabwire-Mangen F, Robb M. Kibuuka H, et al. PLoS One. 2009;4(4):e5164. doi: 10.1371/journal.pone.0005164. Epub 2009 Apr 10. PLoS One. 2009. PMID: 19360102 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page